Ionis Pharmaceuticals, Inc.II

Ionis Pharmaceuticals, Inc.

33.45USDR
+0.54+1.64%
Last update at Mar 24, 23:41 GMT
32.10USD
−1.35−4.04%
No tradesPre-marketLast update at 08:14 GMT
See on Supercharts

IONS fundamentals

Ionis Pharmaceuticals, Inc. revenue breakdown overview

Ionis Pharmaceuticals, Inc. revenue for the last year amounted to 705.00 M USD, the most of which — 705.14 M USD — came from its highest performing source at the moment, Human Therapeutic Medicines, the year earlier bringing 787.65 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Ionis Pharmaceuticals, Inc. 705.14 M USD, and the year before that — 787.65 M USD.

By source
2017
2018
2019
2020
2021
2022
2023
2024
‪0.00‬
‪‪210.00 M‬‬
‪‪420.00 M‬‬
‪‪630.00 M‬‬
‪‪840.00 M‬‬
Human Therapeutic Medicines
Ionis Core
Akcea Therapeutics
Currency: USD
2017
2018
2019
2020
2021
2022
2023
2024
Human Therapeutic Medicines
‪‪810.46 M‬‬
‪‪587.37 M‬‬
‪‪787.65 M‬‬
‪‪705.14 M‬‬
Ionis Core
‪‪622.94 M‬‬
Akcea Therapeutics
‪‪152.32 M‬‬
By country
2017
2018
2019
2020
2021
2022
2023
2024
‪0.00‬
‪‪210.00 M‬‬
‪‪420.00 M‬‬
‪‪630.00 M‬‬
‪‪840.00 M‬‬
United States
Currency: USD
2017
2018
2019
2020
2021
2022
2023
2024
United States
‪‪729.26 M‬‬
‪‪810.46 M‬‬
‪‪587.37 M‬‬
‪‪787.65 M‬‬
‪‪705.14 M‬‬